DN
Therapeutic Areas
AKL Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| APPA | Knee Osteoarthritis (with moderate to severe pain and nociplastic pain features) | Phase 2b |
| Drug | Indication | Phase |
|---|---|---|
| APPA | Knee Osteoarthritis (with moderate to severe pain and nociplastic pain features) | Phase 2b |